Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

The Genomic Landscape of Multiple Myeloma Complex Structural Variations

Blood (2017) 130 (Supplement 1): 330.

https://doi.org/10.1182/blood.V130.Suppl_1.330.330

Published: 2017

Journal Articles

Hydroxycarbamide Plus Aspirin Vs Aspirin Alone in Intermediate Risk Essential Thrombocythemia: Results of the PT-1 International, Prospective, Randomized Clinical Trial

Anna L. Godfrey, BMBCh, PhD MRCP, FRCPath, Peter J Campbell, MD PhD, Cathy MacLean, BSc, MSc, MBA, Georgina Buck, BSc, MSc, Clare L. East, BSc, Julia Cook, BSc, Julie Temple, BSc, Bridget S. Wilkins, MD FRCPath, Keith Wheatley, DPhil, Jyoti Nangalia, MBBChir, MA, MRCP, FRCPath, PhD, Jacob Grinfeld, MBChB, BSc, MRCP, FRCPath, Mary Frances Frances McMullin, MB,Bch BAO, MD FRCPath, Cecily Forsyth, MB BS, Jean-Jacques Kiladjian, MD PhD, Anthony R. Green, FRCP, FRCPath, FMed Sci, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath

Blood (2017) 130 (Supplement 1): 319.

https://doi.org/10.1182/blood.V130.Suppl_1.319.319

Published: 2017

Journal Articles

Abnormalities in Mitochondrial DNA Copy Number Have Pathogenetic and Prognostic Implications in Multiple Myeloma

Blood (2017) 130 (Supplement 1): 4378.

https://doi.org/10.1182/blood.V130.Suppl_1.4378.4378

Published: 2017

Journal Articles

Biological and Prognostic Impact of Apobec-Induced Mutations in the Spectrum of Plasma Cell Dyscrasias

Blood (2017) 130 (Supplement 1): 1771.

https://doi.org/10.1182/blood.V130.Suppl_1.1771.1771

Published: 2017

Journal Articles

Personalized Prognostic Predictions for Patients with Myeloproliferative Neoplasms through Integration of Comprehensive Genomic and Clinical Information

Blood (2017) 130 (Supplement 1): 491.

https://doi.org/10.1182/blood.V130.Suppl_1.491.491

Published: 2017

Journal Articles

The Complex Landscape of Rearrangements in Smoldering and Symptomatic Multiple Myeloma Revealed By Whole-Genome Sequencing

Blood (2016) 128 (22): 236.

https://doi.org/10.1182/blood.V128.22.236.236

Published: 2016

Journal Articles

Clincial and Genetic Landscapes Differ Between IGH-CRLF2 and P2RY8-CRLF2 Acute Lymphoblastic Leukaemia

Lisa Jane Russell, PhD, Lisa Jones, BSc, Amir Enshaei, PhD, Jamie Rutherford, BSc, Stefano Tonin, PhD, Sarra Ryan, PhD, Jeyanthy Eswaran, PhD, Elli Papaemmanuil, PhD, Jose Tubio, PhD, Peter J Campbell, MD PhD, Anthony V Moorman, PhD, Christine Harrison, PhDFRCPath FMedSci

Blood (2015) 126 (23): 1426.

https://doi.org/10.1182/blood.V126.23.1426.1426

Published: 2015

Journal Articles

Sf3b1 K700E Mutation Impairs Pre-mRNA Splicing and Definitive Hematopoiesis in a Conditional Knock-in Mouse Model

Annalisa Mupo, PhD, Vijitha Sathiaseelan, Michael Seiler, PhD, David Kent, PhD, Shouyong Peng, PhD, Ruben Bautista, Suruchi Pacharne, Barry Rosen, Manousos Koutsourakis, Nicla Manes, Frances Law, Elli Papaemmanuil, PhD, Silvia Buonamici, PhD, Peter J Campbell, MD PhD, Niccolo Bolli, MD PhD, George S. Vassiliou, MD PhD

Blood (2015) 126 (23): 140.

https://doi.org/10.1182/blood.V126.23.140.140

Published: 2015

Journal Articles

Genomic Landscape and Its Prognostic Implications in Multiple Myeloma Using a Targeted Sequencing Approach

Niccolo Bolli, MD PhD, Hervé Avet-Loiseau, MD, Silvia Gimondi, Yilong Li, Vijitha Sathiaseelan, Adam Samuel Sperling, MD PhD, Kenneth C Anderson, MD, Stephane Minvielle, Peter J Campbell, MD PhD, Nikhil C. Munshi, MD

Blood (2015) 126 (23): 370.

https://doi.org/10.1182/blood.V126.23.370.370

Published: 2015

Journal Articles

Personally Tailored Risk Prediction of AML Based on Comprehensive Genomic and Clinical Data

Moritz Gerstung, PhD, Elli Papaemmanuil, PhD, Inigo Martincorena, PhD, Lars Bullinger, MD, Verena I. Gaidzik, MD, Peter Paschka, MD, Michael Heuser, MD, Felicitas Thol, MD, Niccolo Bolli, MD PhD, Peter Ganly, BMBCh, PhD, Arnold Ganser, MD, Ultan McDermott, MD PhD, Michael R Stratton, MD PhD, Konstanze Döhner, MD, Hartmut Döhner, Prof. Dr., Richard F. Schlenk, MD, Peter J Campbell, MD PhD

Blood (2015) 126 (23): 85.

https://doi.org/10.1182/blood.V126.23.85.85

Published: 2015

Journal Articles

Somatic Mutations in MDS Patients Are Associated with Clinical Features and Predict Prognosis Independent of the IPSS-R: Analysis of Combined Datasets from the International Working Group for Prognosis in MDS-Molecular Committee

Blood (2015) 126 (23): 907.

https://doi.org/10.1182/blood.V126.23.907.907

Published: 2015

Journal Articles

Dissecting Genetic and Phenotypic Heterogeneity to Map Molecular Phylogenies and Deliver Personalized Outcome and Treatment Predictions in AML

Elli Papaemmanuil, PhD, Moritz Gerstung, PhD, Lars Bullinger, MD, Verena I. Gaidzik, MD, Peter Paschka, MD, Michael Heuser, MD, Felicitas Thol, MD, Niccolo Bolli, MD, Arnold Ganser, MD, Konstanze Dohner, MD, Richard F. Schlenk, MD, Hartmut Dohner, MD, Peter J Campbell, MD PhD

Blood (2015) 126 (23): 803.

https://doi.org/10.1182/blood.V126.23.803.803

Published: 2015

Journal Articles

Redefining Mutational Profiling Using RNA-Seq: Insight into the Functional Mutational Landscape of Multiple Myeloma

David Mosen-Ansorena, PhD, Niccolo Bolli, MD, Mehmet K Samur, PhD, Florence Magrangeas, Stephane Minvielle, Kenneth C Anderson, MD, Peter J Campbell, MD PhD, Hervé Avet-Loiseau, MD, Giovanni Parmigiani, PhD, Nikhil C. Munshi, MD

Blood (2015) 126 (23): 837.

https://doi.org/10.1182/blood.V126.23.837.837

Published: 2015

Journal Articles

An Integrative Genomics Approach Uncovers the Basis of Resistance to AZA Therapy in MDS and CMML

Blood (2015) 126 (23): 710.

https://doi.org/10.1182/blood.V126.23.710.710

Published: 2015

NARROW

The Genomic Landscape of Multiple Myeloma Complex Structural Variations

Hydroxycarbamide Plus Aspirin Vs Aspirin Alone in Intermediate Risk Essential Thrombocythemia: Results of the PT-1 International, Prospective, Randomized Clinical Trial

Abnormalities in Mitochondrial DNA Copy Number Have Pathogenetic and Prognostic Implications in Multiple Myeloma

Biological and Prognostic Impact of Apobec-Induced Mutations in the Spectrum of Plasma Cell Dyscrasias

Personalized Prognostic Predictions for Patients with Myeloproliferative Neoplasms through Integration of Comprehensive Genomic and Clinical Information

The Complex Landscape of Rearrangements in Smoldering and Symptomatic Multiple Myeloma Revealed By Whole-Genome Sequencing

Clincial and Genetic Landscapes Differ Between IGH-CRLF2 and P2RY8-CRLF2 Acute Lymphoblastic Leukaemia

Sf3b1 K700E Mutation Impairs Pre-mRNA Splicing and Definitive Hematopoiesis in a Conditional Knock-in Mouse Model

Genomic Landscape and Its Prognostic Implications in Multiple Myeloma Using a Targeted Sequencing Approach

Personally Tailored Risk Prediction of AML Based on Comprehensive Genomic and Clinical Data

Somatic Mutations in MDS Patients Are Associated with Clinical Features and Predict Prognosis Independent of the IPSS-R: Analysis of Combined Datasets from the International Working Group for Prognosis in MDS-Molecular Committee

Dissecting Genetic and Phenotypic Heterogeneity to Map Molecular Phylogenies and Deliver Personalized Outcome and Treatment Predictions in AML

Redefining Mutational Profiling Using RNA-Seq: Insight into the Functional Mutational Landscape of Multiple Myeloma

An Integrative Genomics Approach Uncovers the Basis of Resistance to AZA Therapy in MDS and CMML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only